Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BerGenBio ASA: Increase of share capital, exercise of share options

Bergen, Norway, 9 November 2021 The Board of Directors in BerGenBio ASA (the"Company") (OSE: BGBIO) have, to fulfil the Company's obligations under the share option agreements and in accordance with the authorization granted by the general meeting on 19 March 2021, resolved to increase the Company's share capital by NOK 7,000 by issuance of 70,000 new shares. The new shares are subscribed for by option owners who wishes and are entitled to exercise options in accordance with the Company's option scheme. Each option gives a right to receive one share in the Company. The subscription price

Notice to Annual General Meeting in ODI Pharma AB (publ)

This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In case of any discrepancies between the Swedish original and this translation, the Swedish version shall prevail. The shareholders of ODI Pharma AB (publ), 559223–1392, are hereby invited to attend the Annual General Meeting on Monday, 13[th] of December 2021, at 10.00 in the office of the company at Östermalmstorg 1, 114 42 Stockholm.Right to participate and registration Shareholders who wish to attend the Annual General Meeting shall · be included

#21-369 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-368 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

LEAX Group contemplates public listing in 2022

LEAX Group AB (“LEAX” or the “Company”) has previously communicated that the Board of Directors and the Company’s owners are assessing the possibilities for a listing of the Company’s shares. Today, LEAX can announce that the Company plans a public listing of the shares in the Company on Nasdaq Stockholm during the first half of 2022 and that the Company has appointed Danske Bank as financial advisor and Gernandt & Danielsson Advokatbyrå as legal advisor in connection with the listing.“We already have a listed bond, and a listing of our shares would be a logical next step in our expansion.

Storskogen publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm

On 14 May 2021, Storskogen Group AB (publ) ("Storskogen") successfully issued senior unsecured bonds in an initial amount of SEK 3 billion, under a total framework of SEK 4 billion (the “Bonds”). The Bonds have a tenor of three years and a floating interest rate of STIBOR three months plus 300 bps.Pursuant to the terms and conditions for the Bonds, Storskogen has undertaken to apply for admission to trading of the Bonds on the corporate bond list of Nasdaq Stockholm. For this purpose, the company has prepared a listing prospectus which today has been approved by the Swedish Financial

Nordnet issues Additional Tier 1 Capital

Nordnet issues Additional Tier 1 Capital to optimize its capital structure. The issuance amounts to SEK 600 million.The bond has a perpetual maturity with a first call option after five years. The interest rate is three months STIBOR + 3.90 percent. Settlement date is 16 November 2021. The bond will be listed at Nasdaq Stockholm. Nordea and SEB have acted as financial advisors in the transaction, and Mannheimer Swartling as legal advisor.

BioGaia AB’s Nomination Committee for the 2022 Annual General Meeting

BioGaia AB’s Nomination Committee for the Annual General Meeting 2022 has been appointed based on the ownership structure as of June 30, 2021. The Nomination Committee consists of: · Per-Erik Andersson, Annwall & Rothschild Investments AB · Fredrik Åtting, EQT · Marianne Flink, AP4 · Carlos Moreno, Premier Milton Investors and  · Peter Rothschild, Chair of the Board BioGaia AB  Shareholders who would like to submit proposals to the Nomination Committee can do so by e-mail to nominationcommittee@biogaia.com or by ordinary mail under the address BioGaia AB, Nomination

SubAir Systems and Soil Scout announce partnership to give groundskeepers unparalleled visibility and operational control of their turf

Soil Scout’s sensors detect the turf’s underground moisture, temperature, and salinity levels while SubAir Systems’ units automatically adjust the moisture levels to provide optimized conditions for turf managersUS-based SubAir Sports Systems  has announced a partnership with wireless underground soil moisture sensor startup Soil Scout  to give turf managers unprecedented control over their operations and turf with automated subsurface monitoring and ventilation.   Soil Scout’s sensor transmits moisture, temperature, and salinity

Sandvik announces first three members of the Board of SMT – the new company planned to be listed in 2022

As previously communicated, the Sandvik Board intends to formally propose the distribution and listing of its business area Sandvik Materials Technology (SMT) at a shareholders' meeting next year, with the target to complete the listing in the second or third quarter of 2022, subject to shareholder approval. The listing is planned to be made at the Nasdaq Stockholm Exchange. As part of this process, the Sandvik Board of Directors has appointed Andreas Nordbrandt as Chairman of the Board of SMT. Additionally, Claes Boustedt and Karl Åberg have been appointed as members of the SMT Board of

Leading Japanese Sushi Chain Deploys Contactless Self-Service Kiosks Powered by Neonode

STOCKHOLM, SWEDEN, November 9, 2021 — Neonode Inc. (NASDAQ: NEON), is pleased to announce that a Neonode customer in Japan has been selected by a leading sushi restaurant chain in Japan to retrofit the chain’s self-service kiosks with Neonode contactless touch technology. The end customer, which is one of the largest sushi restaurant chains in Japan, has decided to deploy a contactless retrofit solution, powered by Neonode touch sensor modules, to all existing self-service kiosks in their over 500 restaurants nationwide. “This is a breakthrough order for Neonode in QSRs (Quick Service

CORRECTION - Mandatory notification of trade - Primary insider

Arild Ingar Moe, EVP and MD NRC Norway, has today purchased 50,000 shares in NRC Group ASA at an average price of NOK 20.06 per share. After the purchase, the correct number of shares held by Arild Ingar Moe is 202,252 shares in NRC Group ASA. Please refer to the attached document for further details of the transaction. This information is subject to the disclosure requirements in Regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section § 5-12.

ABS Offers a Single Interface for Compliance and Maintenance Systems

Secure APIs enable any maintenance system to integrate with ABS MyFreedom™ Client Portal(HOUSTON) ABS clients can now connect their Computerized Maintenance Management System (CMMS) directly to the ABS MyFreedom™ client portal, providing a single interface for survey, compliance and maintenance reporting for the first time improving efficiency and reducing crew workload. The integration enables digital survey crediting, providing a more condition-based approach to support an efficient and streamlined onboard class experience.  The integration has been fully implemented in the ABS

Nomination Committee in Paradox Interactive AB appointed

In accordance with the decision taken by Paradox Interactive AB's Annual General Meeting 2021, the three largest shareholders in the company have the right to each appoint a member of the Nomination Committee. In addition, the Chairman of the Board shall be a member of the Nomination Committee. The three largest shareholders in the company have now each appointed a member, whereby the Nomination Committee for Paradox Interactive AB's Annual General Meeting 2022 has the following members. · Per Håkan Börjesson (Chairman of the Committee), appointed by Investment Aktiebolaget Spiltan

Making sustainable and profitable savings easier

Would you like to contribute to the climate transition while helping your savings grow? The UN trade organisation estimates that annual investments in the region of USD 5-7 trillion is needed to reach the Sustainable Development Goals in the 2030 Agenda for Sustainable Development, including measures aimed at combating climate change. “Investing in a sustainable manner should be both easy and profitable,” says Rebecca Jansson at Handelsbanken Fonder.At present, an estimated one out of three investors choose sustainable funds, according to a survey by the Swedish Investment Fund

Elicera Therapeutics enters agreement with BioNTech for contract manufacturing of viral vectors for CAR T-cell therapy

Gothenburg, November 9, 2021 - Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company that develops immunooncological treatments focusing on CAR T-cells and oncolytic viruses, announced today that it has entered into an agreement with BioNTech for contract manufacturing regarding viral vectors for the company's CAR T-cell therapy, ELC-401.BioNTech IMFS is a contract development and manufacturing organization in Germany that specializes in the industrialization of cell and gene therapies such as virus vectors and cell products. Elicera Therapeutics has entered into an

Kanthal signs licensing agreement regarding MW-scale gas heating solution

Swedish companies Kanthal and Nycast enter an exclusive licensing agreement regarding a large-scale electric gas heating solution developed by Nycast.Kanthal announced today that the company has signed an exclusive licensing agreement with Nycast, a Swedish company that develops electric process gas heating solutions. Under the agreement, Kanthal has the exclusive right to use Nycast’s technology for heating large amounts of process gas at high pressure up to 1,100°C/2,012°F. The technology is a key component for industries with a need to heat high volumes of process gas to high

Mandatory notification of trade - Primary insider

Arild Ingar Moe, EVP and MD NRC Norway, has today purchased 50,000 shares in NRC Group ASA at an average price of NOK 20.06 per share. After the purchase, Arild Ingar Moe holds 252,252 shares in NRC Group ASA. Please refer to the attached document for further details of the transaction. This information is subject to the disclosure requirements in Regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section § 5-12.

Mandatory notification of trade – primary insider

The following primary insider in Multiconsult ASA has purchased shares in Multiconsult ASA:Sverre Hurum, Board member in Multiconsult ASA has on 11 November 2021 purchased 6 000 shares in Multiconsult ASA purchased at an average price of NOK 154.5034 per share and will after the transaction hold 21 000 shares in Multiconsult ASA.In addition, Havgatt AS holds 866 shares in Multiconsult. Mr. Hurum owns 50% of the shares in Havgatt AS, the remaining 50% is owned by a related party to Mr. Hurum.For further information, please contact:    Investor relations:      Pål-Sverre Jørgensen,

Wyld Networks to collaborate with AgriSound on beehive monitoring pilot

Wyld Networks today announces a partnership with AgriSound, the acoustic technology innovators, to develop solutions to aid in the maintenance and optimization of the pollination environment.By combining acoustic technology with environmental sensors, AgriSound have developed a range of innovative products that aid in maintaining an optimal pollination environment, necessary not just for the survival of our future pollinators, but to support agricultural productivity and promote the health of the planet.  Without pollinators, especially bee colonies, 70% of all food crops would be at

Everysport Media Group recruits Lisa Villman as new CFO

Everysport Media Group AB (publ.) (ESMG) has recruited Lisa Villman as new Chief Financial Officer (CFO). Lisa comes most recently from Voi and will begin her new role at ESMG in January. Current CFO Alexander Rödström will also take up his new role as Chief Operating Officer (COO) for the business area Everysport Media Lisa Villman comes most recently from Voi and has extensive experience of leading roles in the financial area. She has previously been Accounting Manager at ESMG and before that had a similar position at MAG Interactive. - I am very happy to welcome Lisa back

BERGENBIO RECEIVES FDA FAST TRACK DESIGNATION FOR BEMCENTINIB IN STK11-MUTATED ADVANCED/METASTATIC NON-SMALL LUNG CANCER (NSCLC)

Bergen, Norway, 9 November 2021 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, today announces that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for bemcentinib in combination with an anti-PD-(L)1 agent as treatment for patients with STK11 altered advanced/metastatic NSCLC patients without actionable mutations. Fast Track designation is intended to facilitate the development and review of drugs used to treat serious conditions and to fill an unmet medical

BERGENBIO PRESENTS PRE-CLINICAL AND CLINICAL DATA ON BEMCENTINIB IN STK11-POSITIVE NSCLC AT SITC ANNUAL MEETING 2021

Bergen, Norway, 9 November 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, is pleased to announce that it will deliver an e-poster presentation at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting, taking place online from 10th-14th November 2021. The e-poster presentation provides pre-clinical and clinical data suggesting that bemcentinib restored response to anti-PD-1 treatments in non-small cell lung cancer (NSCLC) patients harboring STK11 mutations. STK11 is an

Targovax announces two posters at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oslo, Norway, 9 November 2021 - Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announces that the posters being presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting now are available at the Company’s website.Both posters are scheduled for presentation 13 November 2021 at the SITC congress. Poster A randomised open-label phase I/II study adding ONCOS-102 totitle: pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 24-

There are no items matching the current filter
There are no more items matching the current filter
Back to top